Aditi Vedi

TL;DR: The introduction of an algorithm-based approach to the management of fever in immunocompromised children resulted in an improvement in practice, meeting international guidelines and achieving sustained results at 5 years after introduction at a tertiary hospital.

TL;DR: CDSS was superior to diagnostic coding in detecting IFI in an inpatient pediatric hematology/oncology cohort, and the functionality of CDSS lends itself to inpatient infectious diseases surveillance but depends on prescriber adherence.

TL;DR: Both cohorts are an important reminder that TBI alone is a significant risk factor for SCFE, with delays in diagnosis due to the atypical clinical and radiological presentation being common, and the risk of developing SCFE must be carefully considered by clinicians and clearly explained to families before embarking on rhGH therapy.

TL;DR: In carefully selected low‐risk febrile neutropenic children, empiric treatment with oral antibiotics is a safe and effective alternative to intravenous antibiotics as they lower the cost of treatment as well as psychosocial burden on these children and their families.